$ELOX

$13.34 +$0.17 (1.29%) Close

$ELOX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.0M shares outstanding

Who owns ELOX?

By type of holder

Institutions 61.9% Insiders 38.1% Everyone else 0.0%

Concentration Top 10 holders own 103.6%

Aggarwal Sumit 41.4% · Nantahala Capital Management, LLC 9.9%

Institutional ownership

61.9%

+61.9 pts vs last qtr

Institutional holders

+22 vs last qtr

Net shares bought

+2.5M

by institutions in Q2 2026

New / sold out

22 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Aberdeen Group plc NEW +400.0K
Nantahala Capital Management, LLC NEW +400.0K

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Eloxx Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+605.9%

+63.00% a year

Each share's claim on the business

−85.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $14.9M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

—

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting ELOX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
NC Nantahala Capital Management, LLC	400.0K	9.91%	NEW	Q2 '26	0.2%
Shares held by quarter Peak holding400.0K (Q2'26) Change over 8 quarters+400.0K Share of the company9.910% Nantahala Capital Management, LLC's full portfolio →
EC EcoR1 Capital, LLC	400.0K	9.91%	NEW	Q2 '26	0.3%
Shares held by quarter Peak holding400.0K (Q2'26) Change over 8 quarters+400.0K Share of the company9.910% EcoR1 Capital, LLC's full portfolio →

Nantahala Capital Management, LLC

400.0K

% of company

9.91%

Change vs last qtr

NEW

Held since

Q2 '26

EcoR1 Capital, LLC

400.0K

% of company

9.91%

Change vs last qtr

NEW

Held since

Q2 '26

20 more super investors behind a free account

See every manager holding Eloxx Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ELOX on Form N-PORT; together they hold 11.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AH abrdn Healthcare Investors abrdn Healthcare Investors	$3.74M	269.1K	6.67%	0.27%	June 30, 2026
AL abrdn Life Sciences Investors abrdn Life Sciences Investors	$1.82M	130.9K	3.24%	0.26%	June 30, 2026

abrdn Healthcare Investors

Position value

$3.74M

% of company

6.67%

% of the fund

0.27%

As of

June 30, 2026

abrdn Life Sciences Investors

Position value

$1.82M

% of company

3.24%

% of the fund

0.26%

As of

June 30, 2026

5 more funds behind a free account

See every fund holding Eloxx Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AS Aggarwal Sumit Insider	1.7M	41.44%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company41.440% Aggarwal Sumit's insider activity →
AL Androski Lindsay Insider	15.8K	0.39%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.390% Androski Lindsay's insider activity →

Aggarwal Sumit

Insider

1.7M

% of company

41.44%

Change vs last qtr

—

Held since

—

Androski Lindsay

Insider

15.8K

% of company

0.39%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Eloxx Pharmaceuticals Inc.

Comments